Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, C.so Bramante 88/90, 10126, Turin, Italy.
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing University, Nanjing, Jiangsu, People's Republic of China.
World J Urol. 2023 Dec;41(12):3867-3876. doi: 10.1007/s00345-023-04642-2. Epub 2023 Oct 12.
Transperineal mpMRI-targeted fusion prostate biopsies (TPFBx) are recommended for prostate cancer diagnosis, but little is known about their learning curve (LC), especially when performed under local anaesthesia (LA). We investigated how operators' and institutions' experience might affect biopsy results.
Baseline, procedure and pathology data of consecutive TPFBx under LA were prospectively collected at two academic Institutions, from Sep 2016 to May 2019. Main inclusion criterion was a positive MRI. Endpoints were biopsy duration, clinically significant prostate cancer detection rate on targeted cores (csCDR-T), complications, pain and urinary function. Data were analysed per-centre and per-operator (with ≥ 50 procedures), comparing groups of consecutive patient, and subsequently through regression and CUSUM analyses. Learning curves were plotted using an adjusted lowess smoothing function.
We included 1014 patients, with 27.3% csCDR-T and a median duration was 15 min (IQR 12-18). A LC for biopsy duration was detected, with the steeper phase ending after around 50 procedures, in most operators. No reproducible evidence in favour of an impact of experience on csPCa detection was found at operator's level, whilst a possible gentle LC of limited clinical relevance emerged at Institutional level; complications, pain and IPSS variations were not related to operator experience.
The implementation of TPFBx under LA was feasible, safe and efficient since early phases with a relatively short learning curve for procedure time.
经会阴磁共振引导下靶向前列腺融合穿刺活检术(TPFBx)被推荐用于前列腺癌的诊断,但对于其学习曲线(LC)知之甚少,尤其是在局部麻醉(LA)下进行时。我们研究了操作者和机构的经验如何影响活检结果。
在两个学术机构,从 2016 年 9 月至 2019 年 5 月,前瞻性地收集了连续接受 LA 下 TPFBx 的基线、手术和病理数据。主要纳入标准是 MRI 阳性。终点是活检持续时间、靶向核心的临床显著前列腺癌检出率(csCDR-T)、并发症、疼痛和尿功能。数据按中心和操作者(≥50 例)进行分析,比较连续患者组,并通过回归和累积和(CUSUM)分析进行比较。使用调整后的低通平滑函数绘制 LC 图。
我们纳入了 1014 例患者,csCDR-T 为 27.3%,中位活检持续时间为 15 分钟(IQR 12-18)。大多数操作者的活检持续时间存在 LC,在大约 50 例操作后斜率更陡峭的阶段结束。在操作者水平上,没有发现经验对 csPCa 检测有影响的可重复证据,而在机构水平上可能出现了轻微的、临床相关性有限的 LC;并发症、疼痛和 IPSS 变化与操作者经验无关。
LA 下实施 TPFBx 是可行的、安全的和高效的,因为在早期阶段就具有相对较短的手术时间学习曲线。